NCT00236756 – A Double-Blind Trial of Topiramate in Subjects With Lennox-Gastaut Syndrome. Posted on March 26, 2020 by tsuperadmin -
NCT00236847 – Double-Blind, Parallel Comparison of Topiramate 300 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy Posted on March 26, 2020 by tsuperadmin -
NCT00236704 – Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures Posted on March 26, 2020 by tsuperadmin -
NCT00253175 – A Comparison Of The Efficacy And Safety Of Topamax® (Topiramate) Tablets Versus Placebo For The Prophylaxis Of Migraine Posted on March 26, 2020 by tsuperadmin -
NCT00230698 – Topiramate (RWJ-17021-000) Monotherapy Clinical Trial in Patients With Recently Diagnosed Partial-Onset Seizures Posted on March 26, 2020 by tsuperadmin -
NCT00236418 – Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures Posted on February 6, 2020 by tsuperadmin -
NCT00035802 – A Randomized, Double-Blind, Multicenter, Placebo-Controlled 4-Week Study of the Safety and Efficacy of Topiramate in Adolescents With Acute Manic or Mixed Episodes of Bipolar I Disorder, With an Optional 6-Month Open-Label Extension Posted on February 6, 2020 by tsuperadmin -
NCT00231608 – The Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity: A 6-Month Double-Blind, Randomized, Placebo-Controlled Study With a 6-Month Open-Label Extension Posted on February 6, 2020 by tsuperadmin -
NCT00231634 – A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy Posted on February 6, 2020 by tsuperadmin -
NCT00231660 – A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Treated With Metformin Posted on February 6, 2020 by tsuperadmin -